Milestone Advisory Partners’s Gilead Sciences GILD Stock Holding History

Milestone Advisory Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$355K	Hold	4,731	–	–	0.29%	44
2023 Q2	$365K	Hold	4,731	–	–	0.33%	41
2023 Q1	$393K	Hold	4,731	–	–	0.36%	44
2022 Q4	$406K	Hold	4,731	–	–	0.3%	45
2022 Q3	$292K	Hold	4,731	–	–	0.22%	54
2022 Q2	$295K	Sell	4,731 -678	-13%	-$42K	0.24%	52
2022 Q1	$322K	Buy	5,409 +2	+0%	+$128	0.17%	61
2021 Q4	$393K	Buy	5,407 +467	+9%	+$32.2K	0.2%	56
2021 Q3	$345K	Buy	4,940 +2	+0%	+$141	0.2%	57
2021 Q2	$340K	Buy	4,938 +2	+0%	+$134	0.18%	59
2021 Q1	$319K	Buy	4,936 +3	+0.1%	+$193	0.17%	50
2020 Q4	$287K	Sell	4,933 -2,425	-33%	-$146K	0.16%	49
2020 Q3	$465K	Hold	7,358	–	–	0.29%	32
2020 Q2	$566K	Sell	7,358 -1,022	-12%	-$78.3K	0.33%	30
2020 Q1	$626K	Sell	8,380 -3,475	-29%	-$240K	0.43%	20
2019 Q4	$770K	Buy	+11,855	New	+$772K	0.4%	31

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Milestone Advisory Partners's GILD Position: Q3 2023 in Review

Milestone Advisory Partners held its Gilead Sciences (GILD) position steady in Q3 2023 at 4,731 shares worth $355K. The position accounts for 0.29% of the portfolio, ranked #44.

Milestone Advisory Partners first reported a position in GILD in Q4 2019 and has held it in 16 quarters since. The position peaked at $770K in Q4 2019. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Milestone Advisory Partners held 4,731 shares of Gilead Sciences worth $355K as of Q3 2023.
Milestone Advisory Partners left its Gilead Sciences share count unchanged in Q3 2023.
Gilead Sciences made up 0.29% of Milestone Advisory Partners's portfolio in Q3 2023, its #44 holding.
Milestone Advisory Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 16 quarters since.
Milestone Advisory Partners's Gilead Sciences position peaked at $770K in Q4 2019.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Milestone Advisory Partners's 13F filing for Q3 2023, filed 8 Nov 2023.